These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. 5-HT3 and 5-HT4 receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon. Briejer MR; Schuurkes JA Eur J Pharmacol; 1996 Jul; 308(2):173-80. PubMed ID: 8840129 [TBL] [Abstract][Full Text] [Related]
45. Presynaptic 5-HT3 receptors evoke an excitatory response in dorsal vagal preganglionic neurones in anaesthetized rats. Wang Y; Ramage AG; Jordan D J Physiol; 1998 Jun; 509 ( Pt 3)(Pt 3):683-94. PubMed ID: 9596791 [TBL] [Abstract][Full Text] [Related]
46. The characterization of the effect of locally applied N-methylquipazine, a 5-HT3 receptor agonist, on extracellular dopamine levels in the anterior medial prefrontal cortex in the rat: an in vivo microdialysis study. Kurata K; Ashby CR; Oberlender R; Tanii Y; Kurachi M; Rini NJ; Strecker RE Synapse; 1996 Dec; 24(4):313-21. PubMed ID: 10638822 [TBL] [Abstract][Full Text] [Related]
47. Inhibitory effect of ethanol on the 5-hydroxytryptamine-induced Bezold-Jarisch reflex--involvement of peripheral 5-HT3 receptors. Malinowska B; Göthert M; Godlewski G; Wróbel B; Bönisch H; Buczko W Eur J Pharmacol; 1995 May; 293(1):71-6. PubMed ID: 7672010 [TBL] [Abstract][Full Text] [Related]
48. Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex. Sévoz C; Callera JC; Machado BH; Hamon M; Laguzzi R Am J Physiol; 1997 Mar; 272(3 Pt 2):H1250-9. PubMed ID: 9087599 [TBL] [Abstract][Full Text] [Related]
49. Competitive antagonism of the mouse 5-hydroxytryptamine3 receptor by bisindolylmaleimide I, a "selective" protein kinase C inhibitor. Coultrap SJ; Sun H; Tenner TE; Machu TK J Pharmacol Exp Ther; 1999 Jul; 290(1):76-82. PubMed ID: 10381762 [TBL] [Abstract][Full Text] [Related]
50. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models. Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176 [TBL] [Abstract][Full Text] [Related]
51. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. Higgins GA; Joharchi N; Sellers EM J Pharmacol Exp Ther; 1993 Mar; 264(3):1440-9. PubMed ID: 8450478 [TBL] [Abstract][Full Text] [Related]
52. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo. Santiago M; Machado A; Cano J Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217 [TBL] [Abstract][Full Text] [Related]
53. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo. Ge J; Barnes NM Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742 [TBL] [Abstract][Full Text] [Related]
54. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells. Bartrup JT; Newberry NR J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467 [TBL] [Abstract][Full Text] [Related]
55. Pharmacological characterization of the 5-hydroxytryptamine receptor mediating relaxation in the rat isolated ileum. Tuladhar BR; Costall B; Naylor RJ Br J Pharmacol; 1996 Sep; 119(2):303-10. PubMed ID: 8886413 [TBL] [Abstract][Full Text] [Related]
56. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia. García-Pedraza JÁ; García M; Martín ML; Eleno N; Morán A J Cardiovasc Pharmacol; 2017 Jan; 69(1):13-22. PubMed ID: 27676327 [TBL] [Abstract][Full Text] [Related]
57. Activity of aortic chemoreceptors in the anaesthetized rat. Brophy S; Ford TW; Carey M; Jones JF J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):821-8. PubMed ID: 9882753 [TBL] [Abstract][Full Text] [Related]
58. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro. Germonpré PR; Joos GF; Pauwels RA Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563 [TBL] [Abstract][Full Text] [Related]
59. Effect of 5-hydroxytryptamine on gastric motility and efferent gastric vagus nerve activity in rats. Yoshioka M; Ikeda T; Togashi H; Saito Y; Saito H Res Commun Chem Pathol Pharmacol; 1990 Oct; 70(1):3-10. PubMed ID: 2263761 [TBL] [Abstract][Full Text] [Related]
60. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Passani MB; Pugliese AM; Azzurrini M; Corradetti R Br J Pharmacol; 1994 Jun; 112(2):695-703. PubMed ID: 8075890 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]